CERo Therapeutics Holdings, Inc. Common Stock (CERO) — Cash Flow Quality Index

Latest as of September 2022: -2.06x

CERo Therapeutics Holdings, Inc. Common Stock (CERO) has a Cash Flow Quality Index of -2.06x as of September 2022. Operating cash flow of $-174.35K is below net income of $84.50K, suggesting accrual-heavy earnings not yet converted to cash. Explore CERO cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-2.06x

Operating CF / Net Income

Operating Cash Flow

$-174.35K

USD

Net Income

$84.50K

USD

Data as of

Sep 2022

Most recent filing

Annual Cash Flow Quality Index for CERo Therapeutics Holdings, Inc. Common Stock (None–None)

Year-by-year earnings quality comparison for CERo Therapeutics Holdings, Inc. Common Stock.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.